What are the top 10 conferences genomic researchers should be attending?
For genomic researchers, the best conferences are not just places to hear talks. They are where new sequencing technologies, sample-prep workflows, computational methods, disease applications, and collaborations often surface before they appear in publications.
- ASHG Annual Meeting: Best overall human genetics and genomics conference
Who should attend: Human genetics researchers, clinical genomics teams, population genetics groups, rare disease researchers, sequencing technology companies, and translational genomics labs.
ASHG is one of the most important annual meetings for human genetics and genomics. The 2026 meeting is scheduled for October 20–24 in Montréal, and ASHG describes the meeting as a place to showcase research, connect with leaders, and explore the latest in genetics and genomics.
Why it matters:
ASHG is ideal for researchers focused on inherited disease, population genomics, variant interpretation, large-scale sequencing studies, polygenic risk, functional genomics, and genomic medicine.
Best for: Human genomics, clinical research, rare disease, population genetics, and variant interpretation.
- AGBT General Meeting: Best for next-generation sequencing technology
Who should attend: Researchers who want early visibility into sequencing platforms, library-prep innovation, single-cell workflows, spatial biology, methylation/epigenomics, and multi-omics.
AGBT positions its General Meeting as a preeminent genome science and technology conference for top global researchers, leaders, and innovators. The 2026 General Meeting was held February 23–26 in Orlando, Florida.
Why it matters:
AGBT is where many sequencing technology companies and genome science leaders preview new methods and applications. It is especially valuable for labs deciding where the field is heading technically.
Best for: NGS platforms, long-read sequencing, single-cell, spatial, multi-omics, and technology scouting.
- Biology of Genomes: Best small, high-science genome biology meeting
Who should attend: Academic PIs, postdocs, graduate students, genome biology researchers, computational genomics groups, and labs working on fundamental genome function.
Cold Spring Harbor Laboratory’s Biology of Genomes meeting is a highly regarded scientific meeting focused on genome biology. The 2027 meeting is scheduled for May 11–15, 2027 at CSHL.
Why it matters:
This is less of a commercial exhibition and more of a research-first meeting. It is strong for discovering emerging biology, unpublished work, and high-quality academic collaborations.
Best for: Functional genomics, genome regulation, population genomics, evolutionary genomics, and computational genomics.
- ESHG Conference: Best European human genetics meeting
Who should attend: Human genetics researchers, clinical geneticists, molecular diagnostics teams, genetic counselors, and translational genomics groups.
The European Society of Human Genetics 2026 conference is planned as a hybrid meeting in Gothenburg, Sweden, June 13–16, 2026. ESHG describes its scope as basic and applied human and medical genetics.
Why it matters:
ESHG is essential for researchers and companies working across European genomics, clinical genetics, diagnostics, genomic medicine, and regulatory/ethical issues in genetic testing.
Best for: Human genetics, medical genetics, clinical genomics, European collaborations.
- Festival of Genomics, Biodata & AI: Best broad-access genomics and biodata event
Who should attend: Genomics researchers, bioinformaticians, translational scientists, pharma/biotech R&D teams, precision medicine groups, and data/AI teams.
The Festival of Genomics, Biodata & AI takes place in both London and Boston. The Boston 2026 event was scheduled for June 3–4, 2026, bringing together more than 2,500 professionals, with eight theatres and 180+ speakers covering omics, AI, biodata, drug discovery, and precision medicine.
Why it matters:
This is a very practical meeting for researchers who want cross-disciplinary exposure beyond core genomics, including AI, multi-omics integration, clinical translation, biodata infrastructure, and industry case studies.
Best for: Multi-omics, AI in genomics, biodata, precision medicine, pharma/biotech translation.
- PAG — Plant & Animal Genome Conference: Best for agricultural, animal, and plant genomics
Who should attend: Plant genomics researchers, animal genomics groups, agricultural biotech teams, breeding/genetics researchers, and comparative genomics labs.
The International Plant and Animal Genome Conference, PAG 33, took place January 9–14, 2026 in San Diego, and PAG 34 is scheduled for January 8–12, 2027 in San Diego. PAG describes the conference as a forum for recent developments and future plans in plant and animal genome projects, with technical presentations, posters, exhibits, and workshops.
Why it matters:
For non-human genomics, PAG is one of the most important global meetings. It is highly relevant for crop improvement, livestock genomics, genome annotation, pangenomes, breeding, and agricultural biotechnology.
Best for: Plant genomics, animal genomics, ag-biotech, breeding, pangenomes.
- ABRF Annual Meeting: Best for genomics core facilities and applied technologies
Who should attend: Genomics core directors, sequencing facility managers, laboratory operations leaders, proteomics/metabolomics core teams, and applied technology researchers.
The 2026 ABRF Annual Meeting was scheduled for March 28–31, 2026 in Pittsburgh. ABRF meetings are especially relevant to shared research resource staff and core facility professionals, with emphasis on technologies, collaboration, and applied science.
Why it matters:
If your lab runs sequencing services, supports users, evaluates sample-prep platforms, manages quality metrics, or makes technology purchasing decisions, ABRF is one of the most practical meetings on the calendar.
Best for: Genomics cores, sequencing operations, multi-omics services, technology evaluation, and lab workflows.
- AACR Annual Meeting: Best for cancer genomics and translational oncology
Who should attend: Cancer genomics researchers, liquid biopsy teams, tumor profiling labs, single-cell oncology groups, translational researchers, and precision oncology companies.
AACR 2026 was held April 17–22 in San Diego and is described by AACR as a major cancer research meeting spanning fundamental, translational, and clinical research. The 2026 program included genomics-relevant themes such as genomic diversity in cancer prevention and treatment.
Why it matters:
For researchers applying genomics to oncology, AACR is a must-attend. It is especially strong for tumor evolution, ctDNA, methylation biomarkers, MRD, single-cell tumor biology, spatial omics, and drug response.
Best for: Cancer genomics, liquid biopsy, ctDNA, MRD, precision oncology, and translational biomarkers.
- ISMB / ISCB: Best for computational genomics and bioinformatics
Who should attend: Bioinformaticians, computational biologists, statistical geneticists, AI/ML researchers, genome informatics teams, and data science groups.
ISMB 2026, ISCB’s flagship conference, is scheduled for July 12–16, 2026 in Washington, D.C. ISCB describes ISMB as its flagship meeting, focused on computational biology.
Why it matters:
As genomic datasets grow larger and more multi-modal, computational methods are often the limiting factor. ISMB is a strong meeting for new algorithms, AI/ML, variant interpretation, genome assembly, network biology, single-cell analysis, and reproducible workflows.
Best for: Bioinformatics, AI/ML in genomics, computational biology, statistical genomics, workflow development.
- AMP Annual Meeting & Expo: Best for molecular diagnostics and clinical genomics
Who should attend: Molecular pathology labs, clinical genomics teams, diagnostic developers, hospital labs, reference labs, precision medicine groups, and regulatory/quality leaders.
AMP’s 2026 Annual Meeting & Expo is scheduled for November 10–14, 2026 in Seattle, with programming focused on molecular pathology, genomics, molecular diagnostics, and precision medicine.
Why it matters:
AMP is highly relevant for researchers translating genomic assays into clinical use, especially in oncology, inherited disease, infectious disease, companion diagnostics, laboratory-developed tests, and reimbursement/regulatory pathways.
Best for: Clinical genomics, molecular diagnostics, precision medicine, pathology, assay validation.
Looking to increase ROI from events? Reach out for a no-cost assessment.